Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,619,952
-
Share change
-
-58,514
-
Total reported value
-
$26,021,000
-
Put/Call ratio
-
0%
-
Price per share
-
$2.45
-
Number of holders
-
42
-
Value change
-
-$224,387
-
Number of buys
-
16
-
Number of sells
-
23
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2022
As of 31 Mar 2022,
Summit Therapeutics Inc. - COM (SMMT) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,619,952 shares.
The largest 10 holders included
Polar Capital Holdings Plc, BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BOOTHBAY FUND MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and UBS Group AG.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.